제약 분야의 제휴 계약(2020-2026년)

Benchmark Collaboration Partnerships Across the Global Biopharma Industry

Free report sample

The Collaboration Deals in Pharmaceuticals report provides a comprehensive analysis of partnership agreements across the global pharmaceutical and biotechnology industry. Designed for business development, licensing, and strategy professionals, the report delivers a clear view of how companies structure collaboration alliances, negotiate financial terms, and share responsibilities across R&D and commercialization partnerships.

Drawing on collaboration deals announced since 2020, the report compiles detailed deal records alongside analysis of partnering trends, financial structures, and leading dealmakers. Each transaction links to an online deal record and, where available, the original contract document-giving users direct insight into the agreements that shape industry partnerships.

Whether you are evaluating a potential partner, benchmarking deal terms, or performing due diligence on collaboration strategies, this report provides the data and contract-level visibility needed to support more informed partnership decisions.

Key Benefits

• Save Significant Research Time

Access a consolidated database of collaboration deals instead of searching multiple databases, press releases, and regulatory filings.

• Benchmark Collaboration Deal Structures

Understand how companies structure collaborative partnerships, including development roles, financial arrangements, and commercialization responsibilities.

• Analyze Financial Deal Terms

Review available data on upfront payments, milestone payments, and royalty structures to benchmark the financial value of comparable deals.

• Access Real Contract Documents

Where available, the report links directly to SEC-filed agreements, allowing you to review the detailed contractual terms behind major collaboration deals.

• Identify the Most Active Collaboration Dealmakers

See which pharmaceutical and biotechnology companies are leading collaboration activity and analyze their partnership strategies.

• Track Market Trends in Collaboration Partnerships

Analyze dealmaking activity across companies, therapeutic areas, and technology types to understand how collaboration strategies are evolving.

What's Included in the Report

Analysis of collaboration dealmaking trends since 2020

Overview of collaboration deal structures and partnering models

Review of the leading collaboration deals by disclosed value

Profiles of the most active collaboration dealmakers

A comprehensive deal directory organized by company, therapeutic area, and technology type

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual collaboration agreements, the report helps you evaluate key contractual elements such as:

• Rights granted or optioned
• Financial payment structures
• Exclusivity provisions
• Intellectual property ownership
• Development, manufacturing, and commercialization responsibilities
• Deal duration and termination provisions
• Why This Report Matters
• Collaboration partnerships are a cornerstone of innovation in the pharmaceutical and biotechnology industries. Understanding how these alliances are structured-and how financial and operational responsibilities are negotiated-can significantly improve partnership outcomes.
• This report provides the real-world data, financial benchmarking, and contract insight needed to structure better collaboration agreements and negotiate more effectively.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in collaboration dealmaking

• 2.1. Introduction
• 2.2. Definition of collaboration deal
• 2.3. Trends in collaboration deals since 2020
  • 2.3.1. Collaboration dealmaking by year
  • 2.3.2. Collaboration dealmaking by phase of development
  • 2.3.3. Collaboration dealmaking by industry sector
  • 2.3.4. Collaboration dealmaking by therapy area
  • 2.3.5. Collaboration dealmaking by technology type
  • 2.3.6. Collaboration dealmaking by most active company
• 2.4. Reasons for entering into collaboration partnering deals
• 2.5. The future of collaboration deals

Chapter 3 - Overview of collaboration deal structure

• 3.1. Introduction
• 3.2. Collaboration agreement structure

Chapter 4 - Leading collaboration deals

• 4.1. Introduction
• 4.2. Top collaboration deals by value

Chapter 5 - Top 25 most active collaboration dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active collaboration dealmakers

Chapter 6 - Collaboration deals including contracts directory

• 6.1. Introduction
• 6.2. Collaboration deals with contracts
• Deal directory
• Deal directory - collaboration dealmaking by companies A-Z
• Deal directory - collaboration dealmaking by therapy area
• Deal directory - collaboration dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of collaboration deals
• Figure 2: Trends in collaboration deal announcements, 2020-2026
• Figure 3: Collaboration deals signed at each phase of development
• Figure 4: Collaboration deals by industry sector
• Figure 5: Collaboration deals by therapy area
• Figure 6: Collaboration deals by technology type
• Figure 7: Top 25 most active collaboration dealmakers
• Figure 8: Top collaboration deals by value
• Figure 9: Most active collaboration dealmakers